ARTICLE | Company News
GlaxoSmithKline's Trizivir approved in EU
January 4, 2001 8:00 AM UTC
Europe granted marketing approval for Trizivir to treat HIV infection. Trizivir is a twice daily pill combining GlaxoSmithKline's Retrovir zidovudine AZT, Epivir lamivudine 3TC and Ziagen abacavir nuc...